Request Info Medical Affairs Prescribing Information Important Safety Information Visit Patient Site

Flexibility for your patients with CIDP

With flexible options, weekly dosing, and the only Ig prefilled syringes, Hizentra provides convenience to fit your patient’s lifestyle.

Jump to:

Patient Preferences
Prefilled Syringes

Hizentra lets you and your CIDP patients personalize their self-infusions by choosing:

Infusion calendar icon

When
to self-infuse (weekly)

Infusion calendar icon

How long
the self-infusions take

Infusion calendar icon

How much
medicine is given per infusion

Infusion calendar icon

How many
infusion sites your patients use

Meet Patti,
a patient with CIDP discussing the real benefits of self-infusing

With Hizentra, patients like Patti can experience the freedom to infuse at a place and time convenient to them

EAN/PNS* guideline recommends tailoring SCIg dose according to individual treatment response1

Review Guideline

*EAN/PNS=European Academy of Neurology/Peripheral Nerve Society.

Insights from a CSL-sponsored Harris Poll survey†

Almost all CIDP patients surveyed agreed that flexibility and options are important in personalizing Ig treatment2

†Online survey of 103 US adults with CIDP who have ever received IVIg (n=56), SCIg in glass vials (n=34), and/or SCIg in prefilled syringes (n=53).

95% strongly/somewhat agree

Not just simple.
Hizentra PFS simple.

Hizentra Prefilled Syringes (PFS) give your patients proven protection with a first and only for Ig

Simple, convenient, and ready to use

  • May reduce steps and effort vs vials
  • Wide range of sizes to meet patient needs
  • Select sizes are directly compatible with common infusion pumps‡
    • – All sizes can be transferred to a pump syringe using a syringe-to-syringe transfer device

‡4 g directly compatible with FreedomEdge® and VersaPump®. 10 g directly compatible with Freedom60® and SCIg60®.3-5 FreedomEdge® and Freedom60® are registered trademarks of KORU Medical Systems, Inc. VersaPump® and SCIg60® are registered trademarks of EMED Technologies Corporation. CSL Behring does not recommend or endorse specific infusion pump brands.

Hizentra 20mL Prefilled Syringe
See videos and instructions on self-infusing with prefilled syringes

Available in 1 g, 2 g, 4 g, and 10 g—the largest size ever for Ig

Vial and Prefilled Syringe sizes

Insights from a CSL-sponsored Harris Poll survey§

Satisfaction with SCIg in prefilled syringes was high among patients surveyed2

At least 91% were very/somewhat satisfied with
  • Ability to personalize treatment
  • Overall convenience
  • Overall ease of administration
  • Ability to fit treatment into their lifestyle

Most SCIg prefilled syringe patients reported a favorable treatment experience§

Less setup and preparation time than reported by vial patients
Little or no effort reported in a higher percentage than vial patients

Of those who have used prefilled syringes and vials,
all preferred SCIg in prefilled syringes over SCIg in vials (n=11)2¶

§In an online survey, at least 48 of 53 people with CIDP who self-infused Ig in prefilled syringes were very/somewhat satisfied with all measures mentioned.

||Defined as total time from opening package to turning on infusion pump, including Ig transfer from vial(s) or prefilled syringe(s) into pump syringes.

¶Qualified respondents with CIDP who have used both SCIg in glass vials and SCIg in prefilled syringes (n=11).

Dosing

Explore tools and information to help you tailor treatment to individual patient needs

Dosing calculator

Hizentra ConnectSM

Find support and training programs to help make Ig therapy accessible and affordable for patients

Hizentra Connect support

Administration

Explore volumes, rates, and other information to help your patients self-administer Hizentra

Administration guidance
References: 1. Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force Second revision. Eur J Neurol. 2021;1-28. https://doi.org/10.1111/ene.14959. 2. Data on File. Available from CSL Behring as DOF HIZ-014. 3. Data on File. Available from CSL Behring as DOF HIZ-017. 4. Freedom60® Infusion System Instructions for Use. KORU Medical Systems. 2023. 5. FreedomEdge® Syringe Infusion System Instructions for Use. KORU Medical Systems. 2023.

View information about Hizentra for:

PI

primary immunodeficiency

CIDP

chronic inflammatory demyelinating polyneuropathy


acuity
You are now leaving the current website.

Do you want to continue?

No Yes